Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
OBJECTIVES We conducted 2 studies to determine the impact of text message immunization reminder-recalls in an urban, low-income… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
Background: Human immunodeficiency virus (HIV)-infected children are at increased risk of meningococcal infection and poor… Expand
Is this relevant?
2012
2012
Given the high morbidity and mortality associated with meningococcal disease, in 2007 the Advisory Committee of Immunization… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BackgroundDespite national recommendations, as of 2009 human papillomavirus (HPV) vaccination rates were low with < 30% of… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The persistence of human bactericidal activity (hSBA) responses in adolescents was assessed 22 months after vaccination with one… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Routine administration of quadrivalent meningococcal conjugate vaccine to adolescents and certain high risk groups is… Expand
Is this relevant?
2008
2008
  • MMWR. Morbidity and mortality weekly report
  • 2008
  • Corpus ID: 25777889
At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine… Expand
Is this relevant?
Review
2007
Review
2007
In January 2005, Food and Drug Administration licensed a new tetravalent (serogroups A, C, Y, W-135) meningococcal conjugate… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The purpose of this statement is to provide the rationale and recommendations for adolescent use of tetanus toxoid, reduced… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?